AbbVie (ABBV) Other Accumulated Expenses (2012 - 2015)

AbbVie (ABBV) has reported Other Accumulated Expenses for 4 consecutive years, with $2.5 billion the latest figure, recorded in Q4 2015.

• In Q4 2015, Other Accumulated Expenses rose 31.54% year-over-year to $2.5 billion; the TTM figure through Dec 2015 stood at $2.5 billion (up 31.54% YoY), while the FY2015 annual figure was $2.5 billion, up 31.54% from the prior year.
• Other Accumulated Expenses rose to $2.5 billion in Q4 2015 per ABBV's latest filing, from $1.9 billion in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.5 billion in Q4 2015 and bottomed at $398.0 million in Q4 2012.
• Historically, Other Accumulated Expenses has averaged $1.6 billion across 4 years, with a median of $1.7 billion in 2013.
• Annual changes were most pronounced in 2013 — Other Accumulated Expenses soared 284.67% — and 2014, when it advanced 26.32%.
• AbbVie's Other Accumulated Expenses stood at $398.0 million in 2012, then jumped by 284.67% to $1.5 billion in 2013, then grew by 26.32% to $1.9 billion in 2014, then surged by 31.54% to $2.5 billion in 2015.
• Business Quant data shows ABBV's Other Accumulated Expenses at $2.5 billion in Q4 2015, $1.9 billion in Q4 2014, and $1.5 billion in Q4 2013.